• Search
  • Advanced Search

Editorial

July 31, 2024


Summarizing the Intentions and Outcomes of Journal of Urologic Oncology 2024 Issue 2
Cheol Kwak
J Urol Oncol. 2024;22(2):97-99.

Invited Review

July 31, 2024


A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting
Isamu Tachibana, Qian Qin, Jacob Taylor, et al.
J Urol Oncol. 2024;22(2):100-104.

In patients with renal cell carcinoma (RCC), the use of immunotherapy (IO) and tyrosine kinase inhibitor (TKI) regimens has proven beneficial in treating metastatic disease. These advances have led to...

Invited Review

July 31, 2024


Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures
Seokhwan Bang, Sung-Hoo Hong
J Urol Oncol. 2024;22(2):105-114.

Inferior vena cava (IVC) thrombi are detected in 4%–10% of patients with renal cell carcinoma (RCC). The 5-year survival rates following radical nephrectomy (RN) with IVC thrombectomy for patients with...

Invited Review

July 31, 2024


Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
Bokyung Ahn, Jinahn Jeong, Yong Il Lee, et al.
J Urol Oncol. 2024;22(2):115-127.

The remarkable advances in our understanding of renal tumor pathogenesis, driven by the widespread application of molecular testing, are reflected in the latest 2022 World Health Organization classification. This updated...

Original Article

July 31, 2024


Diagnostic Accuracy of Contrast-Enhanced Ultrasonography for the Assessment of Small Renal Mass: A Prospective Study
Jae-Wook Chung, Seo Young Park, Seunghee Woo, et al.
J Urol Oncol. 2024;22(2):128-135.

Purpose: We prospectively compared the diagnostic accuracy of kidney dynamic computed tomography (KDCT), magnetic resonance imaging (MRI), and contrast-enhanced ultrasonography (CEUS) for the assessment of small renal mass (SRM) (≤4...

Original Article

July 31, 2024


Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study
Younsoo Chung, Seok-Soo Byun, Sung Kyu Hong, et al.
J Urol Oncol. 2024;22(2):136-143.

Purpose: We compared the surgical outcomes of radical nephrectomy (RN) and partial nephrectomy (PN) in adult patients with clinical T2 stage (cT2) renal cell carcinoma (RCC) by utilizing data from...

Invited Review

July 31, 2024


Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, et al.
J Urol Oncol. 2024;22(2):144-149.
Prostate cancer shows significant racial disparity, with men of African ancestry disproportionately impacted. While prostate cancer health disparity studies focus on elucidating the contributing socioeconomic, lifestyle, environmental, biological and underlying...

Review Article

July 31, 2024


The Integral Role and Clinical Significance of Metabolic Profiling in Prostate Cancer: A Narrative Review
Valentin Nikolaevich Pavlov, Marat Fayazovich Urmantsev, Marat Radikovich Bakeev, et al.
J Urol Oncol. 2024;22(2):150-156.

Prostate cancer (PC) is the most commonly diagnosed malignancy among males worldwide. In recent years, there has been a need to find alternative methods for the early diagnosis of PC....

Original Article

July 31, 2024


Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study
Si Hyun Kim, Chang Wook Jeong, Minh-Tung Do, et al.
J Urol Oncol. 2024;22(2):157-165.

Purpose: The use of gallium-68 prostate-specific membrane antigen-11 positron emission tomography/computed tomography (Ga-68 PSMA-11 PET/CT) is becoming increasingly common among men with prostate cancer (PCa). However, it remains uncertain which...

Invited Review

July 31, 2024


The Role of Fibroblast Growth Factor Receptors Inhibitors in Bladder Cancer
Ho Kyung Seo, Eui Hyun Jung, Sora Yang, et al.
J Urol Oncol. 2024;22(2):166-177.

Dysregulation of fibroblast growth factor (FGF)-receptor (FGFR) signaling, which is implicated in various oncogenic processes, including tumor proliferation, survival, migration, invasion, and angiogenesis, has been identified as a critical factor...

Original Article

July 31, 2024


Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer
Matthew DeSanto, Frank H. Annie, Stacie Deslich, et al.
J Urol Oncol. 2024;22(2):178-182.
Purpose: The objective of this large retrospective cohort study is to better understand the relationship of bladder cancer and depression incidence, specifically relating to the incorporation of neoadjuvant chemotherapy (NCT)...

Erratum: Correction of Funding Information

July 31, 2024


Erratum: Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy
Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.
J Urol Oncol. 2024;22(2):183-183.
Current Issue
Volume 22(2); Jul 2024
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer  (5,615 times)
Jaewoon Jeong, Jae Baek Ha, In Ho Chang
Korean J Urol Oncol. 2022;20(1):12-24.

Review Article

Feb 24, 2022
The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer  (5,064 times)
Jae Young Joung, Sung Han Kim
Korean J Urol Oncol. 2022;20(1):1-11.

Review Article

Feb 24, 2022
The Present and Future of Intravesical Therapy in Bladder Cancer  (4,410 times)
Sin-Woo Seong, Youngjae Shin, In Ho Chang, et al.
Korean J Urol Oncol. 2022;20(2):82-91.

Review Article

May 26, 2022
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer  (4,360 times)
Jeong Hee Hong
Korean J Urol Oncol. 2022;20(4):207-222.

Review Article

Nov 30, 2022
Complex Epidemiology of Prostate Cancer in Asian Countries  (4,355 times)
Kagenori Ito, Takahiro Kimura
J Urol Oncol. 2023;21(1):5-13.

Review Article

Mar 31, 2023
Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study  (4,000 times)
Minsu Choi, Teak Jun Shin, Byung Hoon Kim, et al.
Korean J Urol Oncol. 2022;20(2):115-122.

Original Article

May 26, 2022
Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?  (3,924 times)
Jae Duck Choi, Jeong Man Cho, Tag Keun Yoo
Korean J Urol Oncol. 2022;20(3):139-150.

Review Article

Aug 25, 2022
Prostate-Specific Antigen Variation as a Predictor of Prostate Cancer in Patients With Prostate-Specific Antigen ≤20 ng/mL Who Underwent Magnetic Resonance Imaging-Targeted Prostate Biopsy  (3,504 times)
Tae Hyun Hwang, Kwang Suk Lee, Kyo Chul Koo, et al.
Korean J Urol Oncol. 2022;20(2):123-132.

Original Article

May 26, 2022
2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS)  (3,351 times)
Chan Ho Lee, Minyong Kang, Cheol Kwak, et al.
Korean J Urol Oncol. 2022;20(3):151-162.

Review Article

Aug 25, 2022
Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer  (3,293 times)
Ja Yoon Ku, Eu Chang Hwang, Chan Ho Lee, et al.
Korean J Urol Oncol. 2022;20(1):52-58.Correction in: J Urol Oncol 2023;21(3):277

Original Article

Feb 24, 2022
Enhanced Recovery After Surgery Program for Radical Cystectomy  (3,263 times)
Whi-An Kwon, Ho Kyung Seo
Korean J Urol Oncol. 2022;20(2):92-106.

Review Article

May 26, 2022
Current Update on Prostate Cancer Immunotherapy  (3,241 times)
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
J Urol Oncol. 2023;21(1):14-22.

Review Article

Mar 31, 2023
Artificial Intelligence on Urology Lab  (3,226 times)
Jae Baek Ha, Jaewoon Jeong, Jeongyoon Suh, et al.
Korean J Urol Oncol. 2022;20(3):163-176.

Review Article

Aug 25, 2022
Clinical Utility of Combining Prostate Health Index and PI-RADS Version 2 to Improve Detection of Clinically Significant Prostate Cancer  (3,151 times)
Wan Song, Chung Un Lee, Jae Hoon Chung, et al.
Korean J Urol Oncol. 2022;20(2):107-114.

Original Article

May 26, 2022
Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer  (3,121 times)
Whi-An Kwon, Ho Kyung Seo
Korean J Urol Oncol. 2022;20(2):71-81.

Review Article

May 26, 2022
Comparison of Perioperative and Oncologic Outcome Between Old Versus Oldest Old After Radical Cystectomy for Bladder Cancer  (3,077 times)
Sang Soo Park, Chung Un Lee, Jae Hoon Chung, et al.
Korean J Urol Oncol. 2022;20(3):186-196.

Original Article

Aug 25, 2022
The Incidence of Prostate-Specific Antigen Test in a Country With a Limited Social Perception of Prostate Cancer 2006-2016: Disparities Manifested by Residential Area  (3,075 times)
Young Hwii Ko, Byung Hoon Kim
Korean J Urol Oncol. 2022;20(1):43-51.

Original Article

Feb 24, 2022
Delaying a Biopsy With Serial Prostate-Specific Antigen Checkup Helps to Identify a Significant Prostate Cancer: A Strategy to Evade Unnecessary Procedures  (2,968 times)
Young Hwii Ko, Byung-Hoon Kim, Wonho Jung, et al.
Korean J Urol Oncol. 2022;20(3):177-185.

Original Article

Aug 25, 2022
Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma  (2,960 times)
Jeong Yoon Suh, Se Jung Maeng, Mirinae Kim, et al.
Korean J Urol Oncol. 2022;20(4):223-234.

Review Article

Nov 30, 2022
A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association  (2,940 times)
Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al.
Korean J Urol Oncol. 2022;20(4):265-272.

Original Article

Nov 30, 2022
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades  (2,820 times)
Sang Heon Han, Hyeong Dong Yuk
J Urol Oncol. 2023;21(1):32-44.

Original Article

Mar 31, 2023

The Landscape of Epidemiology in Urologic Cancers
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up  (2,799 times)
Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
J Urol Oncol. 2023;21(1):70-78.

Original Article

Mar 31, 2023
De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors  (2,757 times)
Sung Han Kim, Eun Young Park, Hyung-Ho Lee, et al.
Korean J Urol Oncol. 2022;20(1):25-33.

Original Article

Feb 24, 2022
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies  (2,667 times)
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al.
J Urol Oncol. 2023;21(1):23-31.

Review Article

Mar 31, 2023
Nanomedicines for Therapy of Bladder Cancer  (2,637 times)
Cheeun Song, Seung Ju Jang, Woo Hyeok Jeon, et al.
Korean J Urol Oncol. 2022;20(4):235-247.

Review Article

Nov 30, 2022
Peripheral T-Cell Lymphoma of Urinary Bladder Presenting With Just Irritative Voiding Symptoms  (2,625 times)
Byung Hoon Kim
Korean J Urol Oncol. 2022;20(2):133-137.

Case Report

May 26, 2022
Solitary Brain Metastasis Detected 1 Year After Robot-Assisted Laparoscopic Radical Nephrectomy: A Case Report  (2,563 times)
Ji Kang Yun, Woong Bin Kim, Si Hyun Kim, et al.
Korean J Urol Oncol. 2022;20(1):63-68.

Case Report

Feb 24, 2022
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy  (2,518 times)
Jin Hyuck Kim, Young Hwii Ko, Jong Wook Kim, et al.
J Urol Oncol. 2023;21(1):79-87.

Original Article

Mar 31, 2023
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients  (2,518 times)
Stefani Frost, Parisa Ziarati, Ryan Moen, et al.
J Urol Oncol. 2024;22(1):78-94.

Systemic Review and Meta-analysis

Mar 31, 2024

Bladder Cancer
Inflammatory Myofibroblastic Tumor of the Urinary Bladder in a Young Patient With Gross Hematuria: A Case Report  (2,512 times)
Han Kyu Chae, Wook Nam, Sung Jin Kim, et al.
Korean J Urol Oncol. 2022;20(1):59-62.

Case Report

Feb 24, 2022

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI